Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CC-5013 for Plasma cell myeloma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where CC-5013 was used for Plasma cell myeloma.

Other Indications for CC-5013

Chronic lymphocytic leukaemia (15) Mantle cell lymphoma (5)

Other Drugs Used for Plasma cell myeloma

LENALIDOMIDE (273,951) POMALIDOMIDE (81,096) DEXAMETHASONE (49,067) BORTEZOMIB (31,567) DARATUMUMAB (19,119) IXAZOMIB (17,602) CARFILZOMIB (15,333) THALIDOMIDE (10,689) CYCLOPHOSPHAMIDE (9,148) REVLIMID (7,122)

Related Pages

CC-5013 Full Profile All Plasma cell myeloma Drugs CC-5013 Demographics CC-5013 Timeline